Vericel on Track for Robust Second Half in 2021 Company Revenue The Numbers The company outperformed expectations so far for 2021 and remains on track to realize growth in the 30% range for the full year. Aug 09, 2021
SI-BONE Takes Cautious View for 2021 Despite Momentum Company Revenue The Numbers Despite continued momentum in its underlying growth trajectory for 2Q21, the company is taking a cautious approach to the balance of the year. Aug 06, 2021
ATEC Drives Adoption of its Surgical Approach Thesis Company Revenue The Numbers In 2Q21 the company more than doubled its revenue from the second quarter of 2019, as adoption of its surgical approaches spread. Aug 05, 2021
SeaSpine Makes Ambitious Investment for 2021 Growth Company Revenue The Numbers The company continued its momentum in 2Q21 and made hefty investments to hit a targeted growth range of +30% to +33% for the full year. Aug 05, 2021
Globus Medical Enters Virtuous Cycles Through Robotics Company Revenue The Numbers The company set a new revenue record in 2Q21 thanks in large part to the synergistic impact of its ExcelsiusGPS robotic system. Aug 05, 2021
Zimmer Biomet Looks to Technology to Untrack Knee Franchise Company Revenue The Numbers In 2Q21 the company made impressive gains in sports medicine and extremities but has yet to find a path to above-market growth in knees. Aug 04, 2021
ConMed Stays the Course During Transition Year Company Revenue The Numbers The company bounced back in 2Q21 from the pandemic low point but, as expected, its orthopedic business remains well off its 2019 pace. Aug 03, 2021
DJO Takes Aim at $1 Billion Recon Business by 2026 Company Revenue The Numbers In 2Q21, the company drove incremental gains over 2019 as markets continue to recover. DJO expects to be a $1 billion recon player by 2026. Aug 02, 2021
Smith+Nephew Facing Questions About Knee Franchise Future Company Revenue The Numbers Although the company finished 2Q21 ahead of its 2019 performance, its knee franchise was double digits for that same comparison period. Jul 30, 2021
Seikagaku Pandemic Recovery Complicated by JOYCLU Side Effects Company Revenue The Numbers While the company's sales increased in FY 1Q21, it issued a safety warning regarding potential side effects of its new JOYCLU product. Jul 30, 2021